Previous studies in humans showed significantly lower plasma obestatin levels in diabetic or non-diabetic obese subjects compared to lean controls but failed to assess diabetes mellitus or impaired glucose tolerance status [18]. This evidence concerns the gene GHRL and Impaired glucose tolerance.